Community health workers improve diabetes care in remote Australian Indigenous communities: results of a pragmatic cluster randomized controlled trial

Table 4 Differences between baseline and follow-up by group

Measure	Group	No.	Mean difference	Std. error of the difference	95% CI meanlower	95% CI meanupper
HbA1c	Control	105	−0.2	0.2	−0.7	0.2
HbA1c	Intervention	83	−1.0	0.2	−1.4	−0.5
S Creatinine	Control	89	18.9	6.9	5.2	32.6
S Creatinine	Intervention	74	32.7	13.4	6.0	59.5
eGFR*	Control	89	−7.2	1.8	−10.7	−3.7
eGFR*	Intervention	74	−10.3	3.1	−16.5	−4.1
UACR	Control	71	41.2	25.3	−9.3	91.8
UACR	Intervention	58	17.6	20.1	−22.7	57.9
Cholesterol	Control	64	−0.3	0.2	−0.6	−0.02
Cholesterol	Intervention	60	−0.6	0.2	−0.9	−0.3
Triglycerides	Control	79	0.1	0.2	−0.4	0.5
Triglycerides	Intervention	64	0.2	0.2	−0.1	0.5
HDL	Control	64	0.06	0.02	0.02	0.09
HDL	Intervention	62	0.06	0.02	0.02	0.1
LDL	Control	56	−0.1	0.1	−0.3	0.2
LDL	Intervention	57	−0.3	0.1	−0.6	−0.1
Cholesterol-HDL ratio	Control	64	−0.3	0.2	−0.6	−0.02
Cholesterol-HDL ratio	Intervention	60	−0.6	0.2	−0.9	−0.3
Weight	Control	72	−1.5	0.6	−2.7	−0.3
Weight	Intervention	71	−0.6	0.7	−2.0	0.8

*Calculated using CKD-EPI formula.
Values in this table calculated as Endpoint- Baseline.
Please note, this calculation is based on only those patients for whom data was collected at both time points excluding 22 loss of follow up. There are a few cases where data was available for only one time point.

ISSN: 1472-6963